ERAS
Price
$1.60
Change
+$0.03 (+1.91%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
445.36M
64 days until earnings call
RVMD
Price
$39.53
Change
+$1.56 (+4.11%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
7.1B
64 days until earnings call
Interact to see
Advertisement

ERAS vs RVMD

Header iconERAS vs RVMD Comparison
Open Charts ERAS vs RVMDBanner chart's image
Erasca
Price$1.60
Change+$0.03 (+1.91%)
Volume$5.78K
Capitalization445.36M
Revolution Medicines
Price$39.53
Change+$1.56 (+4.11%)
Volume$35.13K
Capitalization7.1B
ERAS vs RVMD Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. RVMD commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a Hold and RVMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (ERAS: $1.57 vs. RVMD: $37.97)
Brand notoriety: ERAS and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 69% vs. RVMD: 82%
Market capitalization -- ERAS: $445.36M vs. RVMD: $7.1B
ERAS [@Biotechnology] is valued at $445.36M. RVMD’s [@Biotechnology] market capitalization is $7.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, ERAS is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 5 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • ERAS’s TA Score: 5 bullish, 4 bearish.
  • RVMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than RVMD.

Price Growth

ERAS (@Biotechnology) experienced а -1.87% price change this week, while RVMD (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 05, 2025.

RVMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.1B) has a higher market cap than ERAS($445M). RVMD YTD gains are higher at: -13.192 vs. ERAS (-37.450). ERAS has higher annual earnings (EBITDA): -135.93M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. ERAS (301M). ERAS has less debt than RVMD: ERAS (49.4M) vs RVMD (133M). ERAS (0) and RVMD (0) have equivalent revenues.
ERASRVMDERAS / RVMD
Capitalization445M7.1B6%
EBITDA-135.93M-883.71M15%
Gain YTD-37.450-13.192284%
P/E RatioN/AN/A-
Revenue00-
Total Cash301M2.14B14%
Total Debt49.4M133M37%
TECHNICAL ANALYSIS
Technical Analysis
ERASRVMD
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
82%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 27 days ago
76%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFCHX17.15-0.08
-0.46%
American Century Focused Intl Gr C
BRXUX16.24-0.08
-0.49%
MFS Blended Research Intl Eq R4
MPLIX15.35-0.08
-0.52%
Praxis International Index I
SIECX12.69-0.10
-0.78%
Saratoga International Equity C
ODIIX134.85-2.07
-1.51%
Invesco Discovery R6

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with OCUL. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
N/A
OCUL - ERAS
53%
Loosely correlated
-2.48%
XNCR - ERAS
53%
Loosely correlated
+0.99%
RVMD - ERAS
53%
Loosely correlated
-0.93%
BEAM - ERAS
51%
Loosely correlated
-2.91%
IRON - ERAS
50%
Loosely correlated
-0.03%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-0.93%
CRNX - RVMD
57%
Loosely correlated
+1.11%
OCUL - RVMD
55%
Loosely correlated
-2.48%
ERAS - RVMD
52%
Loosely correlated
N/A
CGON - RVMD
52%
Loosely correlated
+0.39%
NRIX - RVMD
51%
Loosely correlated
-0.74%
More